Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-22-007057
Filing Date
2022-05-16
Accepted
2022-05-16 17:01:03
Documents
2
Period of Report
2022-05-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-56161.html 3  
1 PRIMARY DOCUMENT marketforms-56161.xml 3 2414
2 POA DOCUMENT poa.htm EX-24 3096
  Complete submission text file 0001214659-22-007057.txt   6821
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
Stelzer Laurie (Reporting) CIK: 0001644348 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35921 | Film No.: 22930549